Whole Exome Sequencing Market Research 2024-2033 - Size, Outlook, Overview And Competitor Analysis

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033

The Business Research Company offers in-depth market insights through Whole Exome Sequencing Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The whole exome sequencing market size has grown rapidly in recent years. It will grow from $2.34 billion in 2023 to $2.8 billion in 2024 at a compound annual growth rate (CAGR) of 19.9%. The growth in the historic period can be attributed to genomic research advancements, precision medicine trends, rare disease diagnosis, pharmaceutical and biotech applications, declining sequencing costs.

The whole exome sequencing market size is expected to see exponential growth in the next few years. It will grow to $5.89 billion in 2028 at a compound annual growth rate (CAGR) of 20.4%. The growth in the forecast period can be attributed to expanding applications in oncology, integration in clinical diagnostics, rise in genetic testing demand, population genomics initiatives, emergence of gene therapies. Major trends in the forecast period include enhanced clinical utility and adoption, decreasing costs of sequencing, focus on data security and privacy, integration with electronic health records, advances in single-cell sequencing.

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=10669&type=smp

Market Segmentation:
The whole exome sequencing market covered in this report is segmented -

1) By Product: Systems, Kits, Services
2) By Technology: Sequencing By Synthesis, Ion Semiconductor Sequencing, Other Technologies
3) By Application: Diagnostics, Drug Discovery And Development, Personalized Medicine, Agriculture And Animal Research
4) By End-User: Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Academic and Research Institutes, Clinical Laboratories, Other End-Users

Major Driver - Rising HIV (Human Immunodeficiency Virus) Prevalence Fuels Expansion Of The Whole Exome Sequencing Market
Increasing HIV (human immunodeficiency virus) prevalence is expected to propel the growth of the whole exome sequencing market going forward. HIV refers to a virus that targets the immune system of the body. Whole exome sequencing is used to provide genomic structures of viruses that are useful for personalized treatment and vaccine designs for HIV. For instance, in April 2023, according to the World Health Organization, a Switzerland-based United Nations agency, HIV remains a major global public health issue, with 38.4 million patients globally in 2021 and 650 000 deaths from HIV-related causes. Therefore, the increasing HIV prevalence is driving the growth of the whole exome sequencing market.

Competitive Landscape:
Major companies operating in the whole exome sequencing market report are Thermo Fisher Scientific Inc.,Illumina Inc.,Eurofins Genomics,Azenta US Inc.,CD Genomics,Psomagen Inc.,Agilent Technologies,BGI Genomics,F. Hoffmann-La Roche Ltd.,QIAGEN Inc.,Macrogen Inc.,Ambry Genetics,Bio-Rad Laboratories Inc.,Bioneer Corporation,Foundation Medicine Inc.,KONICA MINOLTA INC.,Otogenetics Corporation,Geneyx Genomex Ltd.,ArcherDX Inc.,Blueprint Genetics Oy,Bionano Genomics Inc.,Centogene AG,Fulgent Genetics Inc.,Natera Inc.,GeneDx Inc.,GENEWIZ Inc.,Novogene Corporation,PerkinElmer Inc.,Personalis Inc.,Clinicient Inc.

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/whole-exome-sequencing-global-market-report

Top Trend - Product Innovation Revolutionizing Whole Exome Sequencing Market
Innovative diagnostic techniques are a key trend gaining popularity in the whole exome sequencing market. Companies operating in the whole exome sequencing market are working on new product innovations to sustain their position in the market. For instance, in February 2023, Illumina Inc., a US-based biotechnology company launched NovaSeqX Plus, the most powerful sequencing technology, delivering an unprecedented combination of high throughput and accuracy and featuring streamlined informatics, sustainability advancements, and economical sequencing. The innovations built into the NovaSeq X Plus systems have the power to generate tens of thousands of whole genomes per year, maximize productivity, and minimize turnaround time.

The Table Of Content For The Market Report Include:

1. Executive Summary
2. Whole Exome Sequencing Market Characteristics
3. Whole Exome Sequencing Market Trends And Strategies
4. Whole Exome Sequencing Market - Macro Economic Scenario
5. Whole Exome Sequencing Market Size And Growth
…..
27. Whole Exome Sequencing Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.